Related Experiment Video
Updated: Jun 12, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (UPDATE 2025)
Francisco Ayala de la Peña1, Silvia Antolín Novoa2, Joaquín Gavilá Gregori3
1Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Hospital Oncológico y de Terapias Avanzadas, Calle Maiquez 7, 28007, Madrid, Spain. frayala@ucm.es.
Abstract:
Breast cancer is the leading cause of cancer in women in Spain and its annual incidence is rapidly increasing. As a result of the screening programs in place, nearly 90% of breast cancer cases are detected in early and potentially curable stages. In recent years, locoregional and systemic therapies have increasingly been directed by new diagnostic tools that have improved the balance between toxicity and clinical benefit. New therapeutic strategies, such as immunotherapy, targeted drugs, and antibody-drug conjugates, have also improved outcomes in some patient subgroups. This clinical practice guideline for early-stage breast cancer (updated in 2025) is based on a systematic review of relevant studies and on the consensus of experts from the Spanish Breast Cancer Research Group (GEICAM), Spanish Collaborative Group for the Study, Treatment and Other Experimental Strategies in Solid Tumors (SOLTI), and Spanish Society of Medical Oncology (SEOM).
Insights
This guideline updates early-stage breast cancer treatment strategies in Spain, incorporating new diagnostic tools and therapies like immunotherapy. It aims to improve patient outcomes while managing treatment toxicity effectively.
Area of Science:
- Oncology
- Clinical Practice Guidelines
Background:
- Breast cancer is the leading cause of cancer among women in Spain, with a rising incidence.
- Screening programs detect most cases at early, curable stages.
- Advances in diagnostics and therapies are improving the efficacy and safety of breast cancer treatment.
Purpose of the Study:
- To provide an updated clinical practice guideline for early-stage breast cancer management.
- To integrate recent advancements in diagnostic tools and therapeutic strategies.
- To offer expert consensus for optimal patient care in Spain.
Main Methods:
- Systematic review of relevant scientific studies.
- Consensus development among experts from GEICAM, SOLTI, and SEOM.
- Focus on early-stage breast cancer (updated for 2025).
Main Results:
- Identification of improved locoregional and systemic therapies.
- Evaluation of novel strategies including immunotherapy, targeted drugs, and antibody-drug conjugates.
- Assessment of enhanced toxicity-benefit balance in treatment.
Conclusions:
- The guideline incorporates new diagnostic and therapeutic advancements for early-stage breast cancer.
- It emphasizes optimizing treatment to improve outcomes and minimize toxicity.
- It serves as a crucial resource for oncologists in Spain.
Related Concept Videos
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...
Standards of Care I
Standards of Care II
Cancer Survival Analysis

